These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 17167772)

  • 1. Effects of OPA1 mutations on mitochondrial morphology and apoptosis: relevance to ADOA pathogenesis.
    Olichon A; Landes T; Arnauné-Pelloquin L; Emorine LJ; Mils V; Guichet A; Delettre C; Hamel C; Amati-Bonneau P; Bonneau D; Reynier P; Lenaers G; Belenguer P
    J Cell Physiol; 2007 May; 211(2):423-30. PubMed ID: 17167772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive survey of mutations in the OPA1 gene in patients with autosomal dominant optic atrophy.
    Thiselton DL; Alexander C; Taanman JW; Brooks S; Rosenberg T; Eiberg H; Andreasson S; Van Regemorter N; Munier FL; Moore AT; Bhattacharya SS; Votruba M
    Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1715-24. PubMed ID: 12036970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OPA1-associated disorders: phenotypes and pathophysiology.
    Amati-Bonneau P; Milea D; Bonneau D; Chevrollier A; Ferré M; Guillet V; Gueguen N; Loiseau D; de Crescenzo MA; Verny C; Procaccio V; Lenaers G; Reynier P
    Int J Biochem Cell Biol; 2009 Oct; 41(10):1855-65. PubMed ID: 19389487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fourteen novel OPA1 mutations in autosomal dominant optic atrophy including two de novo mutations in sporadic optic atrophy.
    Baris O; Delettre C; Amati-Bonneau P; Surget MO; Charlin JF; Catier A; Derieux L; Guyomard JL; Dollfus H; Jonveaux P; Ayuso C; Maumenee I; Lorenz B; Mohammed S; Tourmen Y; Bonneau D; Malthièry Y; Hamel C; Reynier P
    Hum Mutat; 2003 Jun; 21(6):656. PubMed ID: 14961560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the Opa1 mitochondrial protein in retinal ganglion cells: its downregulation causes aggregation of the mitochondrial network.
    Kamei S; Chen-Kuo-Chang M; Cazevieille C; Lenaers G; Olichon A; Bélenguer P; Roussignol G; Renard N; Eybalin M; Michelin A; Delettre C; Brabet P; Hamel CP
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4288-94. PubMed ID: 16249510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial DNA content is decreased in autosomal dominant optic atrophy.
    Kim JY; Hwang JM; Ko HS; Seong MW; Park BJ; Park SS
    Neurology; 2005 Mar; 64(6):966-72. PubMed ID: 15781809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OPA1 (Kjer type) dominant optic atrophy: a novel mitochondrial disease.
    Delettre C; Lenaers G; Pelloquin L; Belenguer P; Hamel CP
    Mol Genet Metab; 2002 Feb; 75(2):97-107. PubMed ID: 11855928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural model of the OPA1 GTPase domain may explain the molecular consequences of a novel mutation in a family with autosomal dominant optic atrophy.
    Dadgar S; Hagens O; Dadgar SR; Haghighi EN; Schimpf S; Wissinger B; Garshasbi M
    Exp Eye Res; 2006 Sep; 83(3):702-6. PubMed ID: 16698014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial dysfunction in an Opa1(Q285STOP) mouse model of dominant optic atrophy results from Opa1 haploinsufficiency.
    Kushnareva Y; Seong Y; Andreyev AY; Kuwana T; Kiosses WB; Votruba M; Newmeyer DD
    Cell Death Dis; 2016 Jul; 7(7):e2309. PubMed ID: 27468686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in Mitochondrial Morphology and Bioenergetics in Human Lymphoblastoid Cells With Four Novel OPA1 Mutations.
    Kao SH; Yen MY; Wang AG; Yeh YL; Lin AL
    Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2269-78. PubMed ID: 25744979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of inner retinal thickness in patients with autosomal dominant optic atrophy associated with OPA1 mutations.
    Ito Y; Nakamura M; Yamakoshi T; Lin J; Yatsuya H; Terasaki H
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4079-86. PubMed ID: 17724190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OPA1, associated with autosomal dominant optic atrophy, is widely expressed in the human brain.
    Bette S; Schlaszus H; Wissinger B; Meyermann R; Mittelbronn M
    Acta Neuropathol; 2005 Apr; 109(4):393-9. PubMed ID: 15700187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective mitochondrial fusion, altered respiratory function, and distorted cristae structure in skin fibroblasts with heterozygous OPA1 mutations.
    Agier V; Oliviero P; Lainé J; L'Hermitte-Stead C; Girard S; Fillaut S; Jardel C; Bouillaud F; Bulteau AL; Lombès A
    Biochim Biophys Acta; 2012 Oct; 1822(10):1570-80. PubMed ID: 22800932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary optic neuropathies share a common mitochondrial coupling defect.
    Chevrollier A; Guillet V; Loiseau D; Gueguen N; de Crescenzo MA; Verny C; Ferre M; Dollfus H; Odent S; Milea D; Goizet C; Amati-Bonneau P; Procaccio V; Bonneau D; Reynier P
    Ann Neurol; 2008 Jun; 63(6):794-8. PubMed ID: 18496845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel deletion in the GTPase domain of OPA1 causes defects in mitochondrial morphology and distribution, but not in function.
    Spinazzi M; Cazzola S; Bortolozzi M; Baracca A; Loro E; Casarin A; Solaini G; Sgarbi G; Casalena G; Cenacchi G; Malena A; Frezza C; Carrara F; Angelini C; Scorrano L; Salviati L; Vergani L
    Hum Mol Genet; 2008 Nov; 17(21):3291-302. PubMed ID: 18678599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OPA1 R445H mutation in optic atrophy associated with sensorineural deafness.
    Amati-Bonneau P; Guichet A; Olichon A; Chevrollier A; Viala F; Miot S; Ayuso C; Odent S; Arrouet C; Verny C; Calmels MN; Simard G; Belenguer P; Wang J; Puel JL; Hamel C; Malthièry Y; Bonneau D; Lenaers G; Reynier P
    Ann Neurol; 2005 Dec; 58(6):958-63. PubMed ID: 16240368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion.
    Zanna C; Ghelli A; Porcelli AM; Karbowski M; Youle RJ; Schimpf S; Wissinger B; Pinti M; Cossarizza A; Vidoni S; Valentino ML; Rugolo M; Carelli V
    Brain; 2008 Feb; 131(Pt 2):352-67. PubMed ID: 18222991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A recurrent deletion mutation in OPA1 causes autosomal dominant optic atrophy in a Chinese family.
    Zhang L; Shi W; Song L; Zhang X; Cheng L; Wang Y; Ge X; Li W; Zhang W; Min Q; Jin ZB; Qu J; Gu F
    Sci Rep; 2014 Nov; 4():6936. PubMed ID: 25374051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation spectrum and splicing variants in the OPA1 gene.
    Delettre C; Griffoin JM; Kaplan J; Dollfus H; Lorenz B; Faivre L; Lenaers G; Belenguer P; Hamel CP
    Hum Genet; 2001 Dec; 109(6):584-91. PubMed ID: 11810270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opa1 deficiency in a mouse model of autosomal dominant optic atrophy impairs mitochondrial morphology, optic nerve structure and visual function.
    Davies VJ; Hollins AJ; Piechota MJ; Yip W; Davies JR; White KE; Nicols PP; Boulton ME; Votruba M
    Hum Mol Genet; 2007 Jun; 16(11):1307-18. PubMed ID: 17428816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.